Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Axsome Therapeutics, Inc.
Axsome Therapeutics Inc is a pharmaceutical company in the United States. It focuses on developing novel therapeutics for the redressal of diseases related to the central nervous system.
IPO Date: November 19, 2015
Sector: Healthcare
Industry: Biotech
Market Cap: $5.01B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.13 | 2.99%
Avg Daily Range (30 D): $1.52 | 1.43%
Avg Daily Range (90 D): $1.91 | 1.68%
Institutional Daily Volume
Avg Daily Volume: .61M
Avg Daily Volume (30 D): .51M
Avg Daily Volume (90 D): .66M
Trade Size
Avg Trade Size (Sh.): 78
Avg Trade Size (Sh.) (30 D): 38
Avg Trade Size (Sh.) (90 D): 42
Institutional Trades
Total Inst.Trades: 3,248
Avg Inst. Trade: $2.88M
Avg Inst. Trade (30 D): $5.86M
Avg Inst. Trade (90 D): $5.96M
Avg Inst. Trade Volume: .04M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $3.56M
Avg Closing Trade (30 D): $7.75M
Avg Closing Trade (90 D): $8.63M
Avg Closing Volume: 53.03K
   
News
Jun 20, 2025 @ 11:00 AM
Axsome Therapeutics Champions Brain Health During ...
Source: N/A
Jun 11, 2025 @ 11:00 AM
Axsome Therapeutics Showcases Innovation in Sleep ...
Source: Axsome Therapeutics
Jun 5, 2025 @ 7:19 AM
2 Soaring Stocks Wth More Upside Potential
Source: Prosper Junior Bakiny
Jun 4, 2025 @ 11:00 PM
Investor Alert: Class Action Lawsuits Against Gene...
Source: Johnson Fistel, Pllp
May 29, 2025 @ 11:00 AM
Axsome Therapeutics to Participate in Upcoming Inv...
Source: N/A
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-5.77 $-1.22 $-1.54
Diluted EPS $-5.77 $-1.22 $-1.54
Revenue $ 432.16M $ 121.46M $ 118.77M
Gross Profit $ $ $
Net Income / Loss $ -278.27M $ -59.41M $ -74.91M
Operating Income / Loss $ -270.27M $ -56.98M $ -72.62M
Cost of Revenue $ $ $
Net Cash Flow $ -30.53M $ -14.44M $ -11.99M
PE Ratio